1 – 93 of 93
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer
2024) In Molecular Oncology(
- Contribution to journal › Article
-
Mark
Molecular patterns of resistance to immune checkpoint blockade in melanoma
(
- Contribution to journal › Article
-
Mark
Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma
(
- Contribution to journal › Article
- 2023
-
Mark
CD169+ Macrophages in Primary Breast Tumors Associate with Tertiary Lymphoid Structures, Tregs and a Worse Prognosis for Patients with Advanced Breast Cancer
(
- Contribution to journal › Article
-
Mark
A deep tabular data learning model predicting cisplatin sensitivity identifies BCL2L1 dependency in cancer
(
- Contribution to journal › Article
-
Mark
Breast cancer associated CD169+ macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells
(
- Contribution to journal › Article
-
Mark
Deciphering the normal-like molecular subtype of breast cancer
2023) AACR Special Conference in Cancer Research: Advances in Breast Cancer Research(
- Contribution to conference › Poster
- 2022
-
Mark
Copy number signatures for early diagnosis of high-grade serous ovarian carcinoma
2022) “FUTURE PERSPECTIVES IN OVARIAN CANCER RESEARCH”(
- Contribution to conference › Poster
-
Mark
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
(
- Contribution to journal › Article
-
Mark
How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer
(
- Contribution to journal › Article
- 2021
-
Mark
Detection of Copy Number Aberration and Tumor Fraction in Archival Cervical Specimens from Ovarian Cancer Patients using Shallow Whole Genome Sequencing.
2021)(
- Contribution to conference › Poster
-
Mark
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
(
- Contribution to journal › Article
-
Mark
Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer
(
- Contribution to journal › Article
-
Mark
Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer
(
- Contribution to journal › Article
-
Mark
MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer
(
- Contribution to journal › Article
-
Mark
Evaluation of multiple transcriptomic gene risk signatures in male breast cancer
(
- Contribution to journal › Article
-
Mark
Homologous recombination repair mechanisms in serous endometrial cancer
(
- Contribution to journal › Article
-
Mark
Protein signature predicts response to neoadjuvant treatment with chemotherapy and bevacizumab in HER2-negative breast cancers
(
- Contribution to journal › Article
-
Mark
Regulatory T lymphocyte infiltration in metastatic breast cancer—an independent prognostic factor that changes with tumor progression
(
- Contribution to journal › Article
-
Mark
Common Susceptibility Loci for Male Breast Cancer
(
- Contribution to journal › Article
- 2020
-
Mark
Simvastatin is a potential candidate drug in ovarian clear cell carcinomas
(
- Contribution to journal › Article
-
Mark
A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients
(
- Contribution to journal › Article
-
Mark
High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer
(
- Contribution to journal › Article
-
Mark
SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery
(
- Contribution to journal › Article
-
Mark
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
(
- Contribution to journal › Article
- 2019
-
Mark
Afadin cooperates with Claudin-2 to promote breast cancer metastasis
(
- Contribution to journal › Article
-
Mark
Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method
(
- Contribution to journal › Article
-
Mark
Extracellular lipid loading augments hypoxic paracrine signaling and promotes glioma angiogenesis and macrophage infiltration
(
- Contribution to journal › Article
-
Mark
Crizotinib and PARP inhibitors act synergistically by triggering apoptosis in high-grade serous ovarian cancer
(
- Contribution to journal › Article
- 2018
-
Mark
Claudin-4 Expression is Associated with Survival in Ovarian Cancer but Not with Chemotherapy Response
(
- Contribution to journal › Article
-
Mark
Ghrelin expression is associated with a favorable outcome in male breast cancer
(
- Contribution to journal › Article
-
Mark
Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer
(
- Contribution to journal › Article
-
Mark
Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer
(
- Contribution to journal › Article
-
Mark
Abstract P3-02-02: Concordance between immunohistochemical and gene-expression based subtyping of early breast cancer using core needle biopsies and surgical specimens - experices from SCAN-B
(
- Contribution to journal › Published meeting abstract
-
Mark
Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab : Results from the Phase II PROMIX trial
(
- Contribution to journal › Article
-
Mark
Characterization of male breast cancer : Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
(
- Contribution to journal › Article
- 2017
-
Mark
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
(
- Contribution to journal › Article
-
Mark
A case-matched gender comparison transcriptomic screen identifies eIF4E and eIF5 as potential prognostic markers in male breast cancer
(
- Contribution to journal › Article
-
Mark
Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread : A case control study
(
- Contribution to journal › Article
-
Mark
Claudin-4 expression is associated with progression free survival in ovarian cancer, but not with chemotherapy response
(
- Contribution to journal › Article
-
Mark
Involvement of chromatin remodeling genes and the Rho GTPases RhoB and CDC42 in ovarian clear cell carcinoma
(
- Contribution to journal › Article
- 2016
-
Mark
Transcriptional profiling of breast cancer metastases identifies liver metastasis-selective genes associated with adverse outcome in luminal A primary breast cancer.
(
- Contribution to journal › Article
- 2015
-
Mark
Global transcriptional changes following statin treatment in breast cancer.
(
- Contribution to journal › Article
-
Mark
Sex Steroid Hormone Receptor Expression Affects Ovarian Cancer Survival.
(
- Contribution to journal › Article
-
Mark
Clinical and molecular complexity of breast cancer metastases.
(
- Contribution to journal › Scientific review
-
Mark
Genome methylation patterns in male breast cancer - Identification of an epitype with hypermethylation of polycomb target genes.
(
- Contribution to journal › Article
-
Mark
Transcriptional profiling of breast cancer metastases identifies liver metastasis-selective genes associated with adverse outcome in luminal A primary breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial.
(
- Contribution to journal › Article
-
Mark
Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications.
(
- Contribution to journal › Article
- 2014
-
Mark
Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes.
(
- Contribution to journal › Article
-
Mark
Nuclear HIF1A expression is strongly prognostic in sporadic but not familial male breast cancer.
(
- Contribution to journal › Article
-
Mark
Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences.
(
- Contribution to journal › Article
-
Mark
Molecular profiling of male breast cancer - Lost in translation?
(
- Contribution to journal › Scientific review
-
Mark
71p * statin-induced anti-proliferative effects via cyclin d1 and p27 in a window-of-opportunity breast cancer trial.
(
- Contribution to journal › Published meeting abstract
-
Mark
32p * biomarkers and molecular subtypes in primary breast tumors and metastases: associations with liver metastases and outcome.
(
- Contribution to journal › Article
-
Mark
Abstract P2-10-28: The Prognostic Index, KiGE, Combining Proliferation, Histological Grade and Estrogen Receptor Status Challenges Gene Profiling – A Study in 1,854 Chemo-Naïve Women with N0/N1 Primary Breast Cancer.
(
- Contribution to journal › Published meeting abstract
- 2013
-
Mark
The Landscape of Candidate Driver Genes Differs between Male and Female Breast Cancer.
(
- Contribution to journal › Article
-
Mark
The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer.
(
- Contribution to journal › Article
-
Mark
Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact
(
- Contribution to journal › Article
-
Mark
Effects of Research Funding, Gender and Type of Position on Research Collaboration Networks: A Micro-level Study of Cancer Research at Lund University
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
High proliferation is associated with inferior Outcome in male breast cancer patients
(
- Contribution to journal › Article
-
Mark
Requirement of Apoptotic Protease-Activating Factor-1 for Bortezomib-Induced Apoptosis but Not for Fas-Mediated Apoptosis in Human Leukemic Cells
(
- Contribution to journal › Article
-
Mark
Cancerforskning vid Lunds universitet: En rapport avseende forskning inom Regionalt Cancercentrum Syd
2013)(
- Book/Report › Report
- 2012
-
Mark
Combination of the proliferation marker cyclin A, histological grade, and estrogen receptor status in a new variable with high prognostic impact in breast cancer.
(
- Contribution to journal › Article
-
Mark
Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk
(
- Contribution to journal › Article
-
Mark
Increased gene copy number of KIT and VEGFR2 at 4q12 in primary breast cancer is related to an aggressive phenotype and impaired prognosis.
(
- Contribution to journal › Article
-
Mark
Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibition.
(
- Contribution to journal › Article
- 2011
-
Mark
Similarities and differences in the characteristics and primary treatment of breast cancer in men and women - a population based study (Sweden)
(
- Contribution to journal › Article
-
Mark
High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer
(
- Contribution to journal › Article
-
Mark
Laser capture microdissection (LCM) and whole genome amplification (WGA) of DNA from normal breast tissue - optimization for genome wide array analyses.
(
- Contribution to journal › Article
- 2010
-
Mark
Genomic alterations in histopathologically normal breast tissue from BRCA1 mutation carriers may be caused by BRCA1 haploinsufficiency.
(
- Contribution to journal › Article
-
Mark
Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
(
- Contribution to journal › Article
- 2008
-
Mark
Tiling array-CGH for the assessment of genomic similarities among synchronous unilateral and bilateral invasive breast cancer tumor pairs.
(
- Contribution to journal › Article
- 2007
-
Mark
RNA quality in frozen breast cancer samples and the influence on gene expression analysis - a comparison of three evaluation methods using microcapillary electrophoresis traces
(
- Contribution to journal › Article
- 2006
-
Mark
Microarrays in breast cancer research and clinical practice - the future lies ahead
(
- Contribution to journal › Scientific review
-
Mark
High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer.
(
- Contribution to journal › Scientific review
-
Mark
Gene Expression Profiling Can Distinguish Tumor Subclasses of Breast Carcinomas.
2006) p.132-132(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
cDNA Microarrays in Cancer Research.
2006) p.13-25(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2005
-
Mark
ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERalpha: a combination therapy potentially targeting hypoxic and dormant tumor cells.
(
- Contribution to journal › Article
-
Mark
Microarray-based Analyses of Hypoxia-induced Transcriptional Changes in Breast Cancer Cell Lines
(
- Contribution to journal › Article
-
Mark
Cyclin E overexpression obstructs infiltrative behavior in breast cancer: a novel role reflected in the growth pattern of medullary breast cancers.
(
- Contribution to journal › Article
- 2003
-
Mark
Molecular classification of familial non-BRCA1/BRCA2 breast cancer
(
- Contribution to journal › Article
-
Mark
Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrier
(
- Contribution to journal › Article
- 2002
-
Mark
Gene expression profiling of hereditary and sporadic ovarian cancers reveals unique BRCA1 and BRCA2 signatures
(
- Contribution to journal › Article
-
Mark
Gene Expression Profiling of Hereditary Breast Cancer
2002)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Gene expression in inherited breast cancer
(
- Contribution to journal › Scientific review
- 2001
-
Mark
Gene-expression profiles in hereditary breast cancer
(
- Contribution to journal › Article
-
Mark
Gene Expression Profiles in Hereditary Breast Cancer – Reply
(
- Contribution to journal › Letter
-
Mark
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis
(
- Contribution to journal › Article
-
Mark
Ny metod möjliggör klassificering av ärftlig bröstcancer.
(
- Contribution to journal › Article
- 2000
-
Mark
MYB oncogene amplification in hereditary BRCA1 breast cancer
(
- Contribution to journal › Article
- 1997
-
Mark
Activated cell cycle checkpoints in epirubicin-treated breast cancer cells studied by BrdUrd-flow cytometry
(
- Contribution to journal › Article